TRENDING :  Market Movers  |  Top 50   SPY (0.37%)    BA (-1.78%)    WTRH (-0.37%)    VXXB (0.25%)    UNIT (-0.32%)    UAA (0.64%)    TVIX (0.08%)    TJX (1.13%)    ASHS (2.11%)    AKTX (12.01%)    ADBE (0.27%)    ACHV (5.32%)    AAT (-0.05%)    SIRI (-1.79%)    SBGI (-2.07%)    ROKU (1.31%)    MMYT (-1.63%)    LRN (-1.49%)    KSU (1.37%)    JMU (4.35%)    JBLU (-0.66%)    GLBS (-17.98%)    DIS (-1.61%)    CDNA (0.74%)    BRS (0%)

 QURE - uniQure N.V.

$65.78 [2.43][3.84%]

Next Earnings

4/29/2019

BMO

Recommend
Trade Idea »



ANALYST RATINGS

Quarterly Rating Chart
Rating

1


1=Strong Buy, 2=Buy, 3=Hold, 4=Underperform, 5=Sell
Price Targets
High $90.00
Low $81.00
Average $85.50
Current $65.78

CompanyAnalyst NamePT ActionActionRatingTargetDate
Wells FargoRaisesMaintainsStrong Buy$90.0003/15/19
Cantor FitzgeraldRaisesMaintainsStrong Buy$81.0002/25/19
*Last 90 days

OPEN RECOMMENDATIONS

No recommendations found.


This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.

TRADERS TRACKING $QURE

Service NameTrader% Success
Swing for the fencesGino Baldassano81.00 %Follow

TRENDING ARTICLES



The Zacks Analyst Blog Highlights: Spark Therapeutics, Solid Biosciences, REGENXBIO, Editas Medicine and uniQure

02/27/19
For Immediate Release Chicago IL February 27 2019 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog

5 Gene Therapy Stocks to Enrich Your Portfolio

02/26/19
The next big thing in the biotech space is shaping up to be gene replacement therapy to treat an array of diseases including inherited bugs It is one of the safest and effective ways to treat specific disease causing genes and it is either done directly in the human body or by extracting

2 More Gene Therapy Stocks on Big Pharma's Buyout Radar

02/26/19
Roche NASDAQOTH RHHBY recently agreed to buy Spark Therapeutics NASDAQ ONCE for a 160 whopping 150 premium over its previous day s closing price and investors want to know which gene therapy stocks could be next to receive a buyout offer from a big pharma with plenty of

Mid-Morning Market Update: Markets Open Higher; Roche To Acquire Spark Therapeutics For $114.50/Share

02/25/19
Following the market opening Monday the Dow traded up 0 65 percent to 26 202 31 while the NASDAQ climbed 0 9 percent to 7 595 47 The S amp P also rose gaining 0 6 percent to 2 809 27 Leading and Lagging Sectors Monday morning the financial shares rose 1 2 percent Meanwhile